| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K33199242 |
| PharmacoGx | BRD-K33199242 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PPIA | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | RPL39 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | TPSG1 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | FAM63A | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | NIPSNAP3A | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | HNRNPH3 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | CD48 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.07 |
| mRNA | RP11-211G3.2 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | SLAIN1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.07 |
| mRNA | PYURF | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
